12:00 AM
 | 
Jan 09, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ceftobiprole regulatory update

Basilea said it plans to submit an MAA to EMA next half for ceftobiprole to treat severe pneumonia in the hospital setting. The announcement follows an audit of 2 Phase III trials of the antibiotic to treat severe community-acquired and hospital-acquired pneumonia that...

Read the full 194 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >